Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes exerts synergism with that ofN-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugate due to its low immunosuppressive activity-Reference-Cited by-同舟云学术

Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes exerts synergism with that ofN-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugate due to its low immunosuppressive activity

Published:2011-04-13 Issue:8 Volume:129 Page:2002-2012
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Tomala Jakub,Chmelova Helena,Strohalm Jiri,Ulbrich Karel,Sirova Milada,Rihova Blanka,Kovar Marek

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF;Mikyskova;Int J Oncol,2004

2. Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation;Ulbrich;J Control Release,2000

3. Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice;Sirova;Cancer Immunol Immunother,2007

4. Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs;Rihova;J Control Release,2002

5. Induction of systemic antitumour resistance with targeted polymers;Rihova;Scand J Immunol,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8⁺T cells;Journal for ImmunoTherapy of Cancer;2023-06

2. Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity;2023-05-04

3. NATURAL IMMUNE BOOSTER IMUREGEN SIGNIFICANTLY AFFECTS THE PROLIFERATION OF TUMOR CELLS;Military Medical Science Letters;2019-09-06

4. Polymer Derivatives of Anticancer Drugs: Features of Synthesis and Biological Activity;Review Journal of Chemistry;2019-01

5. Immunomodulatory Therapies for Renal Cell Carcinoma;Protein & Peptide Letters;2018-08-28